Agile Therapeutics, Inc. Marketable Securities (Current)
Agile Therapeutics, Inc. had Marketable Securities (Current) of $0 as of 2021-12-31, per its 10-K filed 2022-03-30.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:MarketableSecuritiesCurrent · last filed 2022-03-30
- 2021-12-31: Marketable Securities, Current $0.00.
- 2021-06-30: Marketable Securities, Current $5.00M.
- 2021-03-31: Marketable Securities, Current $23.65M.
- 2020-12-31: Marketable Securities, Current $40.01M.
| Period end | Marketable Securities, Current |
|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-03-30 |
| 2021-06-30 | $5.00M 10-Q · filed 2021-07-26 |
| 2021-03-31 | $23.65M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $40.01M 10-K · filed 2022-03-30 |
| 2020-09-30 | $47.74M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $47.79M 10-Q · filed 2020-08-11 |